Regulation 33 of SEBI(LODR) 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Unjha Formulations Limited announced its unaudited Q1 FY26 results (quarter ended 30 June 2025). Total income from operations stood at Rs. 363.40 lakhs, up sharply from Rs. 243.90 lakhs in Q1 FY25, a growth of about 49% year-on-year. Profit for the quarter came in at Rs. 38.99 lakhs versus Rs. 32.96 lakhs in the year-ago quarter, a growth of roughly 18%. Total expenses rose from Rs. 210.91 lakhs to Rs. 324.41 lakhs, a 54% jump that kept earnings growth modest despite the strong topline. The Board approved the results at its meeting on August 6, 2025, and statutory auditors M/s Jain & Golechha issued an unqualified limited review report. The company operates in a single business segment and reported no pending investor complaints.
The robust 49% revenue growth is a positive signal, but the faster rise in expenses (54%) limited PAT growth to about 18%, suggesting margin pressure that retail investors should monitor. The clean auditor review report and absence of any qualified remarks or exceptional items are reassuring for now.